Journal of Psychoactive Drugs

{{short description|Peer-reviewed medical journal on psychoactive drugs}}

{{Infobox journal

| title = Journal of Psychoactive Drugs

| image =

| caption =

| former_name = Journal of Psychedelic Drugs

| abbreviation = J. Psychoact. Drugs

| discipline = Pharmacology

| language = English

| editor =

| publisher = Taylor & Francis

| country =

| history = 1967–present

| frequency =

| openaccess =

| license =

| impact = 2.80

| impact-year = 2022

| ISSN = 0279-1072

| eISSN = 2159-9777

| CODEN =

| JSTOR =

| LCCN =

| OCLC =

| website = http://www.tandfonline.com/loi/ujpd20/

| link1 =

| link1-name =

| link2 =

| link2-name =

}}

The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs.{{cite journal | vauthors = Doblin RE, Christiansen M, Jerome L, Burge B | title = The Past and Future of Psychedelic Science: An Introduction to This Issue | journal = J Psychoactive Drugs | volume = 51 | issue = 2 | pages = 93–97 | date = 2019 | pmid = 31132970 | doi = 10.1080/02791072.2019.1606472 | url = }} It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980.{{cite web |url=http://www.erowid.org/library/periodicals/journals/journals_jopd.shtml |title=Erowid Periodical Library: The Journal of Psychedelic Drugs |publisher=Erowid.org |date= |accessdate=2008-10-07}}{{Cite web|title=Journal of Psychoactive Drugs information|url=https://www.tandfonline.com/action/journalInformation?journalCode=ujpd20&|access-date=2022-02-24|website=www.tandfonline.com}} It was the first journal established in the United States to focus on psychoactive drug use, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, methadone maintenance treatment, and culturally-relevant substance abuse treatment. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.740.{{cite book |year=2013 |chapter=Journal of Psychoactive Drugs |title=2012 Journal Citation Reports |publisher=Thomson Reuters |edition=Science |series=Web of Science |title-link=Journal Citation Reports }}